In Press
Chen DT, Tomohiro MKo Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, and O’Brien CP (in press). Personal control over decisions to participate in research by persons with histories of both substance use disorders and criminal justice supervision. Journal of Empirical Research on Human Research Ethics.
Fletcher JB, Swendeman D, Reback CJ (in press). Associations Between Major Depressive Episode, Methamphetamine Use Disorder Severity, and Engagement in Sexual Risk-Taking Among Methamphetamine-Using Men Who Have Sex with Men. AIDS and Behavior. doi: 10.1007/s10461-017-1974-4. PMID: 29164354.
Gordon MS, Blue TR, Couvillion K, Schwartz RP, O’Grady KE, Fitzgerald TT & Vocci FJ (in press). Impact of Starting Buprenorphine Treatment Prior to vs. After Release from Prison: Arrest Outcomes. Drug and Alcohol Dependence.
Monico LB, Gryczynski J, Schwartz RP, Jaffe JH, O’Grady KE, & Mitchell SG (in press). Treatment outcomes among a cohort of African American buprenorphine patients: Follow-up at 12-months. American Journal of Drug and Alcohol Abuse.
Zhang S, Shoptaw S, Reback CJ, Yadav K and Nyamathi A (in press). Cost-Effective Way to Reduce Stimulant Abuse among Gay/Bisexual Men and Transgender Women: A Randomized Clinical Trial with a Cost Comparison. Public Health.
2018
Friedmann PD, Wilson D, Nunes EV, Hoskinson Jr R, Lee JD, Gordon MS, Murphy SM, Bonnie RJ, Chen DT, Boney TY, O’Brien CP (2018). Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder? Journal of Substance Abuse Treatment.
Gordon MS, Crable EL, Carswell SB, Leopold J, Hodo-Powell J, McKenzie M, and Rich JD (2018). A randomized controlled trial of intensive case management (Project Bridge) for HIV-infected probationers and parolees. AIDS and Behavior. 22(3):1030-1038. doi: 10.1007/s10461-017-2016-y.
Gryczynski J, Carswell SB, O’Grady KE, Mitchell SG, Schwartz RP (2018). Gender and ethnic differences in primary care patients' response to computerized vs. in-person brief intervention for illicit drug misuse. Journal of Substance Abuse Treatment. 84:50-56. doi: 10.1016/j.jsat.2017.10.009.
Mitchell SG, Monico LB, Lertch E, Kelly SM, Gryczynski J, Jaffe J, O’Grady KE, & Schwartz RP (2018). Counseling staff's views of patient-centered methadone treatment: Changing program rules and staff roles. Journal of Behavioral Health Services and Research.
Monico LB, Mitchell SG (2018). Patient perspectives on transitioning from prescription opioids to heroin and the role of route of administration. Substance Abuse Treatment, Prevention, and Policy.
Nunes EV, Gordon MS, Friedmann PD, Fishman MJ, Lee JD, Chen DT, Hi MC, Boney TB, Wilson D, O’Brien CP (2018). Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. Journal of Substance Abuse Treatment.
Soares W, Wilson D, Rathlev N, Lee J, Gordon MS, Nunes E, O’Brien CP, Friedmann P (2018). Healthcare Utilization in Adults with Opioid Dependence receiving Extended Release Naltrexone compared to Treatment as Usual. Journal of Substance Abuse Treatment. /10.1016/j.jsat.2017.05.009.
2017
Allen A, Chen D, Bonnie RJ, Koa TM, Surratt CE, Lee JD, Friedmann P, Gordon MS, McDonald R, Murphy S, Boney T, Nunes E, O’Brien CP (2017). Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision. Journal of Substance Abuse Treatment. 81, 66–72.
Anderson-Carpenter KD, Fletcher JB, Reback CJ (2017). Associations between Methamphetamine Use, Housing Status, and Incarceration Rates among Men Who Have Sex with Men and Transgender Women. Journal of Drug Issues. 47(3):383-395. doi: 10.1177/0022042617696917. Epub 2017 Mar 9. PMID: 28670005.
Carswell SB, Gordon MS, Gryczynski J, and Tangires S (2017). The daily progress system: A proof of concept pilot study of a recovery support technology tool for outpatient substance abuse treatment. The American Journal of Drug and Alcohol Abuse. Published online: 30 May 2017.
Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, Biggs ML, Cunningham W, Chris Delaney JA, Flynn PM, Golin CE, Knight K, Kral AH, Kuo I, Lorvick J, Nance RM, Ouellet LJ, Rich JD, Sacks S, Seal D, Spaulding A, Springer SA, Taxman F, Wohl D, Young JD, Young R, Crane HM (2017). Cohort profile: seek, test, treat and retain United States criminal justice cohort. Substance Abuse Treatment, Prevention, and Policy. 12(1):24. doi: 10.1186/s13011-017-0107-4. PMID:28511680.
Fletcher JB, Reback CJ (2017). Mental health disorders among homeless, substance-dependent men who have sex with men. Drug and Alcohol Review. 36(4):555-559. doi: 10.1111/dar.12446. Epub 2016 Aug 12. PMID: 27516073.
Gordon MS (2017). Television interview with Investigative Reporter Barry Sims of WBAL-TV Channel 11. Long-acting naltrexone for prisoners.
Gordon MS, Carswell SB, Peters EN, Tangires S, Kinlock TW, Vocci FJ, and Restivo L (2017). Avatar assisted therapy: A novel technology-based Intervention to treat substance use disorders. In Pam Lassiter (ed.), Annual Review of Addictions and Offender Counseling: Best Practices III. (p 97 - 114). Eugene, OR: Wipf & Stock Publishers.
Gordon MS, Carswell SB, Schadegg M, Mangen K, Merkel K, Tangires S, Vocci FJ (2017). Avatar-assisted therapy: a proof-of-concept pilot study of a novel technology-based intervention to treat substance use disorders. American Journal of Drug and Alcohol Abuse. 43(5):518-524. doi: 10.1080/00952990.2017.1280816.
Gordon MS, Crable EL, Carswell SB, Leopold J, Hodo-Powell J, McKenzie M, and Rich JD (2018). A randomized controlled trial of intensive case management (Project Bridge) for HIV-infected probationers and parolees. AIDS and Behavior. 22(3):1030-1038. doi: 10.1007/s10461-017-2016-y.
Gordon MS, Fitzgerald TT (2017). Television interview with Maryland Department of Public Safety Reporter Gerard Shields. Long-acting naltrexone for prisoners.
Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE, Fitzgerald TT, Vocci FJ (2017). A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release. Drug and Alcohol Dependence. 172:34-42. doi: 10.1016/j.drugalcdep.2016.11.037. Epub 2017 Jan 11. PMID: 28107680.
Gordon MS, Vocci FJ, Fitzgerald TT, O’Grady KE, O’Brien CP (2017). Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. Contemporary Clinical Trials. 53:130-136. doi: 10.1016/j.cct.2016.12.015. PMID:28011389.
Gryczynski J, McNeely J, Wu LT, Subramaniam GA, Svikis DS, Cathers LA, Sharma G, King J, Jelstrom E, Nordeck CD, Sharma A, Mitchell SG, O’Grady KE, Schwartz RP (2017). Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. Journal of General Internal Medicine. 32(9):990-996. doi: 10.1007/s11606-017-4079-x. Epub 2017 May 26. PMID: 28550609.
Gryczynski J, Nordeck CD, Mitchell SG, Page KR, Johnsen LL, O’Grady KE, Schwartz RP (2017). Pilot Studies Examining Feasibility of Substance Use Disorder Screening and Treatment Linkage at Urban Sexually Transmitted Disease Clinics. Journal of Addiction Medicine. 11(5):350-356. doi: 10.1097/ADM.0000000000000327. PMID: 28590392.
Kelly SM, O’Grady KE, Gryczynski J, Mitchell SG, Kirk A, Schwartz RP (2017). The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health center. Substance Abuse. 38(4):382-388. doi: 10.1080/08897077.2017.1351413. Epub 2017 Jul 7. PMID: 28686545.
Kussin-Shoptaw AL, Fletcher JB, Reback CJ (2017). Physical and/or Sexual Abuse Is Associated with Increased Psychological and Emotional Distress Among Transgender Women. LGBT Health. 4(4):268-274. doi: 10.1089/lgbt.2016.0186. Epub 2017 May 12. PMID: 28498023.
Loeliger KB, Biggs ML, Young R, Seal DW, Beckwith CG, Kuo I, Gordon MS, Altice FL, Ouellet LJ, Cunningham WE, Young JD, Springer SA (2017). Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A "Seek, Test, Treat, and Retain" Harmonization Consortium. AIDS and Behavior. doi. 10.1007/s10461-017-1722-9. PMID:28188460.
Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M (2017). Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm. Journal of Addiction Medicine. 11(3):211-216. doi: 10.1097/ADM.0000000000000299. PMID:28252456.
Nance RM, Delaney JA, Golin CE, Wechsberg WM, Cunningham C, Altice F, Christopoulos K, Knight K, Quan V, Gordon MS, Springer S, Young J, Crane PK, Mayer KH, Mugavero MJ, Del Rio C, Kronmal RA, Crane HM (2017). Co-calibration of two self-reported measures of adherence to antiretroviral therapy. AIDS Care. 29(4):464-468. doi: 10.1080/09540121.2016.1263721.
Reback CJ, Fletcher JB (2017). Outcomes from a Homegrown HIV Prevention Program for Extremely High-risk, Substance-using Men who have Sex with Men with Multiple Health Disparities. Journal of Gay & Lesbian Social Services. DOI: 10.1080/10538720.2017.1296394.
Reback CJ, Rünger D, Fletcher JB (2017). Physical and/or Sexual Abuse Are Associated with Negative Health Outcomes among Transgender Women of Color Living with HIV. Violence and Gender. 4(4): 130-136. DOI: 10.1089/vio.2017.0042.
Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group (2017). The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 107(2):224-229. doi: 10.2105/AJPH.2016.303582. PMID: 28075641.
Rusow JA, Fletcher JB, Reback CJ (2017). Sexual Venue Choice and Sexual Risk-Taking Among Substance-Using Men Who have Sex with Men. AIDS and Behavior. 21(4):1149-1162. doi: 10.1007/s10461-016-1630-4. PMID: 27905014.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2017). Patient‐centered methadone treatment: a randomized clinical trial. Addiction. 112(3):454-64.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Jaffe JH (2017). When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records. Drug and Alcohol Dependence. 180:385-390. doi: 10.1016/j.drugalcdep.2017.08.025. Epub 2017 Sep 14. PMID: 28961545.
Schwartz RP, McNeely J, Wu LT, Sharma G, Wahle A, Cushing C, Nordeck CD, Sharma A, O’Grady KE, Gryczynski J, Mitchell SG, Ali RL, Marsden J, Subramaniam G (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment. 76, 69-76.
Sharma A, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2017). Update on Barriers to Pharmacotherapy for Opioid Use Disorders. Current Psychiatry Reports. 19(6):35. doi: 10.1007/s11920-017-0783-9. Review. PMID: 28526967.
Shoptaw S, Landovitz RJ, Reback CJ (2017). Contingent Vs. Non-Contingent Rewards: Time-Based Intervention Response Patterns Among Stimulant-Using Men Who Have Sex With Men. Journal of Substance Abuse Treatment. 72:19-24. doi: 10.1016/j.jsat.2016.09.004. Epub 2016 Sep 13. PMID: 27938777.
Sigmon SC, Schwartz RP, Higgins ST (2017). Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence. New England Journal of Medicine. 376(10):1000-1001. doi: 10.1056/NEJMc1700539. No abstract available. PMID: 28273017.
Stitzer ML, Schwartz RP, Bigelow GE (2017). Prescription opioids: New perspectives and research on their role in chronic pain management and addiction. Drug and Alcohol Dependence. 173 Suppl 1:S1-S3. doi: 10.1016/j.drugalcdep.2016.11.018. No abstract available. PMID: 28363314.
Wu LT, McNeely J, Subramaniam GA, Brady KT, Sharma G, VanVeldhuisen P, Zhu H, Schwartz RP (2017). DSM-5 substance use disorders among adult primary care patients: Results from a multisite study. Drug and Alcohol Dependence. 179:42-46. doi: 10.1016/j.drugalcdep.2017.05.048. Epub 2017 Jul 13. PMID: 28753480.
Zaller N, Gordon MS, Bazerman L, Kuo I, Beckwith C (2017). Individuals under community supervision in Baltimore, MD. Journal of Correctional Healthcare. 23(3), 305-312.
2016
Chandler RK, Finger MS, Farabee D, Schwartz RP, Condon T, Dunlap LJ, Zarkin GA, McCollister K, McDonald RD, Laska E, Bennett D, Kelly SM, Hillhouse M, Mitchell SG, O’Grady KE, Lee J (2016). The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Contemporary Clinical Trials. 48:166-72. doi: 10.1016/j.cct.2016.05.003. PMID: 27180088.
Fletcher JB, Reback CJ (2016). Mental health disorders among homeless, substance-dependent men who have sex with men. Drug and Alcohol Review. doi: 10.1111/dar.12446.
Glasner-Edwards S, Patrick K, Ybarra ML, Reback CJ, Rawson RA, Garneau HC, Chavez Kand Venegas A (2016). A Cognitive Behavioral Therapy Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users. Journal of Medical Internet Research, Research Protocols. 5(2).
Gordon MS, Carswell SB, Wilson M, Kinlock TW, Restivo LL, McKenzie M, Rich JD, (2016). Factors Associated With Receiving Rapid HIV Testing Among Individuals on Probation or Parole. Journal of Correctional Health Care. 22(4):290-299. PMID: 27742854.
Gryczynski J, O’Grady KE, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse. Journal of Addiction Medicine. 10(5):344-51. doi: 10.1097/ADM.0000000000000248. PMID: 27504925.
Gryczynski J, Schwartz RP, O’Grady KE, Restivo LL, Mitchell SG, Jaffe JH (2016). Understanding patterns of high-cost health care use across different substance user groups. Health Affairs. (Millwood). 35(1):12-9. doi: 10.1377/hlthaff.2015.0618. PMID: 26733696 PMCID: PMC4936480 DOI: 10.1377/hlthaff.2015.0618.
Hong YA, Mitchell SG, Peterson JA, Latkin C, Tobin K (2016). Ethnographic process evaluation. Monitoring and Evaluation in Health and Social Development: Interpretive and Ethnographic Perspectives. 159.
Hunter SB, Schwartz RP, Friedmann PD (2016). Introduction to the Special Issue on the Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and/or Drug Use Interventions and Medical Care. Journal of Substance Abuse Treatment. 60:1-5. doi: 10.1016/j.jsat.2015.10.001. Epub 2015 Oct 20. PMID: 26549295.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2016). Corrigendum to "Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients" [Drug Alcohol Depend. 140 (2014) 213-216]. Drug and Alcohol Dependence. 168:203. doi: 10.1016/j.drugalcdep.2016.09.012. PMID: 27697697.
Kinlock TW, and Gordon MS (2016). Heroin and Other Opiates. In Henry H. Brownstein (ed.). The Handbook of Drugs and Society. (pp. 72-89). West Sussex, UK: John Wiley & Sons, Inc.
McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, Sleiter L, Russell L, Nordeck C, Sharma A, O’Grady KE, Bouk LB, Cushing C, King J, Wahle A, Schwartz RP (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine. 165(10):690-699. doi: 10.7326/M16-0317. PMID: 27595276.
Mitchell SG, Schwartz RP, Kirk AS, Dušek K, Oros M, Hosler C, Gryczynski J, Barbosa C, Dunlap L, Lounsbury D, O’Grady KE, Brown BS (2016). SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers. Journal of Substance Abuse Treatment. 60:81-90. doi:10.1016/j.jsat.2015.06.011. Epub 2015 Jun 26. PMID: 26297321.
Mitchell SG, Willett J, Monico LB, James A, Rudes DS, Viglioni J, Schwartz RP, Gordon MS, Friedmann PD (2016). Community Correctional Agents' Views of Medication-Assisted Treatment: Examining their Influence on Treatment Referrals and Community Supervision Practices. Substance Abuse. 37(1):127-33. doi: 10.1080/08897077.2015.1129389. PMID: 26860334. PMCID: PMC4823810.
Monico LB, Mitchell SG, Welsh W, Link N, Hamilton L, Malvini Redden S, Schwartz RP, Friedmann PD (2016). Developing effective interorganizational relationships between community corrections and community treatment providers. Journal of Offender Rehabilitation. 55(7):484-501.
Monico LB, Schwartz RP, Gryczynski J, O’Grady KE, Mitchell SG (2016). Two models of integrating buprenorphine treatment and medical staff within formerly "drug-free" outpatient programs. Journal of Psychoactive Drugs. 48(2):101-8. doi: 10.1080/02791072.2015.1130884. PMID: 26940870.
O’Grady KE, Gryczynski J, Mitchell SG, Ondersma SJ, Schwartz RP (2016). Confirmatory factor analysis of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in community health center patients. American Journal on Addictions. 25(4):259-63. doi: 10.1111/ajad.12360. PMID: 27037633.
Ondersma SJ, Gryczynski J, Mitchell SG, O’Grady KE, Schwartz RP (2016). Process evaluation of a technology-delivered screening and brief intervention for substance use in primary care. Internet Interventions. 4(Pt 1):11-16. PMID: 27110494PMCID: PMC4836054. DOI: 10.1016/j.invent.2016.01.004.
Pines HA, Gorbach PM, Weiss RE, Reback CJ, Landovitz RJ, Mutchler MG, Mitsuyasu RT (2016). Individual-Level, Partnership-Level, and Sexual Event-Level Predictors of Condom Use During Receptive Anal Intercourse Among HIV-Negative Men Who Have Sex with Men in Los Angeles. AIDS and Behavior. 20(6), 1315-1326.
Reback CJ, Kaplan RL, Bettcher TM, Larkins S (2016). The role of the illusion in the construction of erotic desire: narratives from heterosexual men who have occasional sex with transgender women. Culture, Health & Sexuality. 18(8), 951-963.
Rosenthal RN, Lofwall MR, Kim S, Chen M, Beebe KL, Vocci FJ (2016). Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: A randomized clinical trial. Journal of the American Medical Association. 316(3), 282-290.
Rusow JA, Fletcher JB, Reback CJ (2016). Sexual Venue Choice and Sexual Risk-Taking Among Substance-Using Men Who have Sex with Men. AIDS and Behavior. 1-14.
Schwartz RP (2016). When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al. Journal of Addiction Medicine. 10(4):283-5. doi: 10.1097/ADM.0000000000000236. PMID: 27471920.
Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O’Grady KE, Jaffe JH (2016). Corrigendum to “Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial”. Contemporary Clinical Trials. 51:97. doi: 10.1016/j.cct.2016.09.008. PMID: 27729206.
Schwartz RP, Kelly SM, Mitchell SG, Dunlap L, Zarkin GA, Sharma A, O’Grady KE, Jaffe JH (2016). Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial. Contemporary Clinical Trials. 49:21-8. doi: 10.1016/j.cct.2016.06.002. PMID: 27282117.
Schwartz RP, Kelly SM, Mitchell SG, Gryczynski J, O’Grady KE, Gandhi D, Olsen Y, Jaffe JH (2016). Patient-centered methadone treatment: a randomized clinical trial. Addiction. doi: 10.1111/add.13622. [Epub ahead of print]. PMID: 27661788.
Serpelloni G, Genetti B, Andreotti A, Sperotto M, Zermiani M, Sharma A, O’Grady KE, Schwartz RP (2016). Prevalence and correlates for alcohol, cigarette, and cannabis use among Italian high school students: a national survey. Substance Abuse and Rehabilitation.
Sharma A, O’Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP (2016). Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Substance Abuse and Rehabilitation. 7:27-40. doi: 10.2147/SAR.S81602. Review. PMID: 27217808. PMCID: PMC4853155 DOI: 10.2147/SAR.S81602.
Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST (2016). Interim Buprenorphine vs. Waiting List for Opioid Dependence. New England Journal of Medicine. 375(25):2504-2505. doi: 10.1056/NEJMc1610047. PMID: 28002704. DOI: 10.1056/NEJMc1610047.
Wu LT, McNeely J, Subramaniam G, Sharma G, VanVelduisen P, Schwartz RP (2016). Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool. Contemporary Clinical Trials. 50:90-7. doi: 10.1016/j.cct.2016.07.013. PMID: 27444426.
Wu LT, McNeely J, Subramaniam GA, Sharma G, VanVeldhuisen P, Schwartz RP (2016). Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 19; 50: 90-97]. Contemporary Clinical Trials. 51:98. doi: 10.1016/j.cct.2016.09.001. PMID: 27665683.
2015
Barbosa C, Dunlap LJ, Wedehase B, Mitchell SG, Schwartz RP, Dušek K, Kirk AS, Oros M, Hosler C, Gryczynski J, Brown BS (2015). Start-up costs of implementing Screening and Brief Intervention (SBI) for Adolescents (part of Economics of SBI symposium). Addiction Science and Clinical Practice. 10 (Suppl 2), O5.
Fletcher JB, Reback CJ (2015). Depression Mediates and Moderates Effects of Methamphetamine Use on Sexual Risk Taking Among Treatment-Seeking Gay and Bisexual Men. Health Psychology. 34(8):865-9. doi: 10.1037/hea0000207. Epub 2015 Jan 12. PMID: 25581704.
Gordon MS, Kinlock TW, Schwartz RP, Couvillion KA, Sudec LJ, O’Grady KE, Vocci FJ, Shabazz H (2015). Buprenorphine Treatment for Probationers and Parolees. Substance Abuse. 36(2):217-25. doi: 10.1080/08897077.2014.902787. Epub 2014 Apr 4. PMID: 24701967.
Gordon MS, Kinlock TW, Vocci FJ, Fitzgerald TT, Memisoglu A, Silverman B (2015). A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners. Journal of Substance Abuse Treatment. 59:52-8. doi: 10.1016/j.jsat.2015.07.005. Epub 2015 Jul 18. PMID: 26299956.
Gryczynski J, Kelly SM, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2015). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients. Addiction. 110(2):240-7. doi: 10.1111/add.12767. Epub 2014 Nov 20. PMID: 25311148.
Gryczynski J, Mitchell SG, Gonzales A, Moseley A, Peterson TR, Ondersma SJ, O’Grady KE, Schwartz RP (2015). A randomized trial of computerized vs. in-person brief intervention for illicit drug use in primary care: outcomes through 12 months. Journal of Substance Abuse Treatment. 50, 3-10. doi: 10.1016/j.jsat.2014.09.002. Epub 2014 Sep 16. PMID: 25282578.
Gryczynski J, Mitchell SG, Jaffe JH, O’Grady KE, Olsen YK, Schwartz RP (2015). Leaving buprenorphine treatment: patients' reasons for cessation of care. Journal of Substance Abuse Treatment. 46(3):356-61. PubMed PMID: 24238714; PubMed Central PMCID: PMC3947058.
Gryczynski J, Mitchell SG, Ondersma SJ, O’Grady KE, Schwartz RP (2015). Potential radiating effects of misusing substances among medical patients receiving brief intervention. Journal of Substance Abuse Treatment. 55:39-44.
Gryczynski J, Nordeck C, Mitchell SG, O’Grady KE, McNeely J, Wu L-T, Schwartz RP (2015). Reference periods in retrospective behavioral self-report: A qualitative investigation. American Journal on Addictions. 24(8): 744-747.
Gryczynski J, Schwartz RP, Mitchell SG, Dzirasa L, Dušek K, O’Grady K, and Cowell A (2015). Preliminary research in preparation for a randomized trial of brief intervention strategies for adolescents in school-based health centers. Addiction Science and Clinical Practice. 10 (Suppl 2), O20. http://doi.org/10.1186/1940-0640-10-S2-O20.
Hall TM, Reback CJ, Shoptaw S (2015). Clinical Management of Substance Use and Substance Use Disorders among LGBT Individuals. In H.J. Makadon, K.H. Mayer, J. Potter, & H. Goldhammer (Eds. The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health. 2nd Edition. Philadelphia: American College of Physicians Books, pp. 227-267.
Kinlock TW and Gordon MS (2015). Pharmacotherapy for Incarcerated Individuals with Histories of Heroin Addiction. In Ayman M. Fareed (ed. Heroin Addiction: Prevalence, Treatment Approaches and Health Consequences. (pp. 127-142). Hauppauge, NY: Nova Science Publishers, Inc.
Landovitz RJ, Fletcher JB, Shoptaw S, Reback CJ (2015). Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infectious Diseases. 1;2(1):ofu114. doi: 10.1093/ofid/ofu114. eCollection 2015 Jan. PMID: 25884003. PMCID: PMC4396429.
Lee JD, Friedmann PD, Boney TY, Hoskinson RA Jr, McDonald R, Gordon MS, Fishman M, Chen DT, Bonnie RJ, Kinlock TW, Nunes EV, Cornish JW, O’Brien CP (2015). Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial. Contemporary Clinical Trials. 41:110-7.
Mitchell SG, Gryczynski J, Schwartz RP, Myers CP, O’Grady KE, Olsen YK, Jaffe JH (2015). Changes in Quality of Life following Buprenorphine Treatment: Relationship with Treatment Retention and Illicit Opioid Use. Journal of Psychoactive Drugs. 47(2):149-57.
Mitchell SG, Monico LB, Gryczynski J, O’Grady KE, Schwartz RP (2015). Staff Views of Acceptability and Appropriateness of a Computer-Delivered Brief Intervention for Moderate Drug and Alcohol Use. Journal of Psychoactive Drugs. 47(4):301-7. doi: 10.1080/02791072.2015.1075631. Epub 2015 Sep 16. PMID: 26375411.
Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, Miele GM, Kunkel LE, Norton M, Stitzer ML (2015). The Use of Technology in Participant Tracking and Study Retention: Lessons Learned from a Clinical Trials Network Study. Substance Abuse. 36(4):420-6. doi: 10.1080/08897077.2014.992565. Epub 2015 Feb 11. PMID: 25671593. PMCID: PMC4532645.
Mitchell SG, Willett J, Swan H, Monico LB, Yang Y, Patterson Y, Belenko S, Vega-Debien Graciela Pankow J, Schwartz RP and Visher C (2015). Defining success: Insights from a random assignment, multi-site study of implementing HIV prevention, testing and linkage to care in US jails and prisons. AIDS Education and Prevention. 27(5):432-45. doi: 10.1521/aeap.2015.27.5.432. PMID: 26485233.
Monico LB, Abdel-Salam S, O’Connell D, Visher C, Martin S (2015). Using Organizational Strategies to Improve Substance Abuse Treatment for Probationers: A Case Study in Delaware. Federal Probation. Dec 2015.
Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH (2015). Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. Journal of Substance Abuse Treatment.   57:89-95. doi: 10.1016/j.jsat.2015.05.005. Epub 2015 May 12. PMID: 25986647.
Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2015). Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of Substance Abuse Treatment. 57:57-62. doi: 10.1016/j.jsat.2015.04.010. Epub 2015 May 7. PMID: 25980599.
Nyamathi A, Reback CJ, Salem BE, Zhang S, Shoptaw S, Branson CM, Leake B (2015). Correlates of self-reported incarceration among homeless gay and bisexual stimulant-using young adults. Western Journal of Nursing Research. 37(6):799-811. doi: 10.1177/0193945914530521. Epub 2014 Apr 14. PMID: 24733231.
Peters EN, Harrell PT, Hendricks PS, O’Grady KE, Pickworth WB, Vocci FJ (2015). Electronic cigarettes in adults in outpatient substance use treatment: Awareness, perceptions, use, and reasons for use. American Journal on Addictions.  24(3):233-9.
Peters EN, Nordeck C, Zanetti G, O’Grady KE, Serpelloni G, Rimondo C, Blanco C, Welsh C, Schwartz RP (2015). Relationship of gambling with tobacco, alcohol, and illicit drug use among adolescents in the USA: Review of the literature 2000-2014. American Journal on Addictions. 24(3):206-16.
Reback CJ, Fletcher JB, Shoptaw S, Mansergh G (2015). Exposure to Theory-Driven Text Messages is Associated with HIV Risk Reduction Among Methamphetamine-Using Men Who have Sex with Men. AIDS and Behavior. 19 Suppl 2:130-41. doi: 10.1007/s10461-014-0985-7. PMID: 25563501.
Reback CJ, Kaplan RL, Larkins S (2015). Disclosure of Male Sexual Partnering and HIV Serostatus Among a Sample of Heterosexually Identified Men Who Have Sex With Men and Women. AIDS Education and Prevention. 27(3):227-39. doi: 10.1521/aeap.2015.27.3.227. PMID: 26010314.
Salem B, Nyamathi A, Reback CJ (2015). Unmet Physical and Mental Healthcare Needs among Stimulant-using Gay and Bisexual Homeless Men. Issues in Mental Health Nursing. 36: 685-692. DOI: 10.3109/01612840.2015.1021938.
Schwartz RP, Kelly SM, Gryczynski J, Mitchell SG, O’Grady KE, Jaffe JH (2015). Heroin use, HIV-risk, and criminal behavior in Baltimore: Findings from Clinical Research. Journal of Addictive Diseases. 34(2-3):151-61. doi: 10.1080/10550887.2015.1059222. PMID: 26079104.
Sigmon SC, Meyer AC, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP (2015). Bridging waitlist delays with Interim Buprenorphine Treatment: Initial feasibility. Addictive Behaviors. 51:136-142.
Visher CA, Yang Y, Mitchell SG, Patterson Y, Swan H, Pankow J (2015). Understanding the Sustainability of Implementing HIV Services in Criminal Justice Settings. Health & Justice. 3(5).
Vocci FJ, Schwartz RP, Wilson ME, Gordon MS, Kinlock TW, Fitzgerald TT, O’Grady KE, Jaffe JH (2015). Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners. Drug and Alcohol Dependence. 156:133-8. doi: 10.1016/j.drugalcdep.2015.09.001. Epub 2015 Sep 7. PMID: 26409751.
Welsh W, Prendergast M, Knight K, Knudsen H, Monico LB, Gray J, Abdel-Salam S, Malvini Redden S, Link N, Hamilton L, Shafer MS, Friedmann P (2015). Correlates of interorganizational service coordination in community corrections. Criminal Justice and Behavior. 43(4):483-505.
Welsh WN, Knudsen HK, Knight K, Ducharme L, Pankow J, Urbine T, Lindsey A, Abdel-Salam S, Wood J, Monico LB, Link N, Albizu-Garcia C, Friedmann PD (2015). Effects of an organizational linkage intervention on interorganizational service coordination between probation/parole agencies and community treatment providers. Administration and Policy in Mental Health Journal. 43(1):105-21.
Welsh WN, Lin H, Peters RH, Stahler GJ, Lehman WEK, Stein LAR, Monico LB, Eggers M, Abdel-Salam S, Pierce JC, Hunt E, Gallagher C, Frisman LK (2015). Effects of a strategy to improve offender assessment practices: Staff perceptions of implementation outcomes. Drug and Alcohol Dependence. 152:230-238.
2014
Bellamoli E, Manganotti P, Schwartz RP, Rimondo C, Gomma M, Serpelloni G (2014). rTMS in the treatment of drug addiction: an update about human studies. Behavioural Neurology. 2014:815215. PubMed PMID: 24803733; PubMed Central PMCID: PMC4006612.
Carswell SB, Hanlon TE, O’Grady KE, Watts AM (2014). Correlates of risky sexual activity for urban African American youth in an alternative education program. Education and Urban Society. 46(4), 434-449. doi:10.1177/0013124512458119.
Carswell SB, Hanlon TE, Watts A, O’Grady KE (2014). Prevention-related research targeting African American alternative education program students. Education and Treatment of Children. 46(4), 434-449. doi:10.1177/0013124512458119.
Fletcher JB, Dierst-Davies R, Reback CJ (2014). Contingency management voucher redemption as an indicator of delayed gratification. Journal of Substance Abuse Treatment. 47(1):73-7. doi: 10.1016/j.jsat.2014.03.003. Epub 2014 Mar 12.PMID:24674235.
Fletcher JB, Shoptaw S, Peck JA, Reback CJ (2014). Contingency Management Reduces Symptoms of Psychological and Emotional Distress among Homeless, Substance-dependent Men Who Have Sex with Men. Mental Health and Substance Use. 7(4):420-430.PMID:25364379.
Gordon MS, Kinlock TW, Schwartz RP, Fitzgerald TT, O’Grady KE, Vocci FJ (2014). A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry. Drug and Alcohol Dependence. 142, 33-40. doi: 10.1016/j.drugalcdep.2014.05.011. Epub 2014 Jun 2. PMID: 24962326.
Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos JM, Silverman K (2014). The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial. Preventative Medicine. 68:62-70. Epub 2014 Mar 4.PMID: 24607365.
Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Silverman K (2014). Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users. Journal of Applied Behavior Analysis. 47(4):681-93. doi: 10.1002/jaba.158. Epub 2014 Oct 8. PMID: 25292399.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. Drug and Alcohol Dependence. 140:213-6. PubMed PMID: 24793367; PubMed Central PMCID: PMC4070874.
Kelly SM, Gryczynski J, Mitchell SG, Kirk A, O’Grady KE, Schwartz RP (2014). Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics. 133(5):819-26. PubMed PMID: 24753528; PubMed Central PMCID: PMC4006430.
Mitchell SG, Gryczynski J, Kelly SM, O’Grady KE, Jaffe JH, Olsen YK, Schwartz RP (2014). Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status. Journal of Drug Issues. 44(1):69-82. PMID:25364037.
Müller-Leonhardt A, Mitchell SG, Vogt J, Schürmann T (2014). Critical Incident Stress Management (CISM) in complex systems: cultural adaptation and safety impacts in healthcare. Accident Analysis and Prevention. 68:172-80. PubMed PMID: 24491831.
Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED (2014). Dopamine D3 receptors as a therapeutic target for methamphetamine dependence. American Journal of Drug and Alcohol Abuse. 40(1):1-9. PubMed PMID: 24359505.
Peters EN, Hendricks PS, Clark CB, Vocci FJ, Cropsey KL (2014). Association of race and age with treatment attendance and completion among adult marijuana users in community-based substance abuse treatment. Journal of Addiction Medicine. 8(2):143-9. PubMed PMID: 24603621.
Peters EN, Schwartz RP, Wang S, O’Grady KE, Blanco C (2014). Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Drug and Alcohol Dependence. 134:228-34. PubMed PMID: 24183498; PubMed Central PMCID: PMC3865597.
Reback CJ, Fletcher JB (2014). HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach. AIDS and Behavior. 18(7):1359-67. doi: 10.1007/s10461-013-0657-z.PMID:24287786.
Reback CJ, Fletcher JB (2014). Reductions in HIV prevalence rates among substance-using men who have sex with men in Los Angeles County, 2008-2011. AIDS Education and Prevention. 26(5):459-70.doi: 10.1521/aeap.2014.26.5.459.PMID:25299809.
Reback CJ, Shoptaw S (2014). Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men. Addictive Behaviors. 39(8):1286-91. doi: 10.1016/j.addbeh.2011.11.029. Epub 2011 Nov 26PMID:22169619.
Reback CJ, Veniegas R, Shoptaw S (2014). Getting Off: development of a model program for gay and bisexual male methamphetamine users. Journal of Homosexuality. 61(4):540-53. doi: 10.1080/00918369.2014.865459.PMID:24245506.
Rusow JA, Fletcher JB, Le H, Reback CJ (2014). Sexual Abuse is Associated with Negative Health Consequences among High-risk Men who have Sex with Men. Journal of Gay & Lesbian Social Services. 26(2):244-257.PMID:25505831.
Schwartz RP, Alexandre PK, Kelly SM, O’Grady KE, Gryczynski J, Jaffe JH (2014). Interim versus standard methadone treatment: a benefit-cost analysis. Journal of Substance Abuse Treatment. 46(3):306-14. doi: 10.1016/j.jsat.2013.10.003. Epub 2013 Oct 14.PMID:24239030.
Teruya C, Schwartz RP, Mitchell SG, Hasson AL, Thomas C, Buoncristiani SH, Hser Y-I, Wiest K, Cohen AJ, Glick N, Jacobs P, McLaughlin P, Ling W (2014). Patient perspectives on buprenorphine/naloxone: A qualitative study of retention during the Starting Treatment with Agonist Replacement Therapies (START) study. Journal of Psychoactive Drugs. 46(5):412-26. doi: 10.1080/02791072.2014.921743. PMID: 25364994.
2013
Blanco C, Iza M, Schwartz RP, Rafful C, Wang S, Olfson M (2013). Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study. Drug and Alcohol Dependence. 131 (1-2), 143-148.
Blanco C, Rafful C, Wall MW, Jin CJ, Kerridge B, Schwartz RP (2013). The latent structure and predictors of non-medical prescription drug use and prescription drug use disorders: a national study. Drug and Alcohol Dependence. 133(2), 473-479.
Defulio A, Stitzer M, Roll J, Petry N, Nuzzo P, Schwartz RP, et al (2013). Criminal justice referral and incentives in outpatient substance abuse treatment. Journal of Substance Abuse Treatment. 45. (1), 70-75.
Fletcher JB, Reback CJ (2013). Antisocial personality disorder predicts methamphetamine treatment outcomes in homeless, substance-dependent men who have sex with men. Journal of Substance Abuse Treatment. 45(3):266-72.
Friedmann PD, Ducharme LJ, Welsh W, Frisman L, Knight K, Kinlock T, Mitchell SG, Hall E, Urbine T, Gordon MS, Abdel-Salam S, O’Connell D, Albizu-Garcia C, Knudsen H, Duval J, Fenster J; Jennifer Pankow for the CJ-DATS MATICCE Workgroup (2013). A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol. Health Justice. 19; 1(6). doi: 10.1186/2194-7899-1-6. PMID: 25309847. PMCID: PMC4193542.
Gordon MS, Kinlock TW, Couvillion KA, Schwartz RP, Wilson ME, O’Grady KE (2013). Gender differences among prisoners with pre-incarceration heroin dependence participating in a randomized clinical trial of buprenorphine treatment. Journal of Offender Rehabilitation. 52(5), 376-391.
Gordon MS, Kinlock TW, McKenzie M, Rich JD, Wilson ME (2013). Rapid HIV testing for individuals on probation/parole: Outcomes of an intervention trial. AIDS and Behavior. 17(6), 2022-2030.
Gordon MS, Kinlock TW, Schwartz RP, Couvillion KA, O’Grady KE (2013). The Severity, Frequency, and Variety of Crime in Heroin-Dependent Prisoners Enrolled in a Buprenorphine Clinical Trial. Prison Journal. 93(4):390-410.
Gryczynski J, Jaffe JH, Schwartz RP, Dušek KA, Gugsa N, Monroe CL, O’Grady KE, Olsen YK, Mitchell SG (2013). Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system. American Journal on Addictions. 22(3):285-91.
Gryczynski J, Mitchell SG, Jaffe JH, Kelly SM, Myers CP, O’Grady KE, Olsen YK, Schwartz RP (2013). Retention in methadone and buprenorphine treatment among African Americans. Journal of Substance Abuse Treatment. 45(3):287-92.
Heinz AJ, Peters EN, Boden MT, Bonn-Miller MO (2013). A comprehensive examination of delay discounting in a clinical sample of cannabis-dependent military veterans making a self-guided quit attempt. Experimental and Clinical Psychopharmacology, 21. 55-65.
Kelly SM, O’Grady KE, Jaffe JH, Gandhi D, Schwartz RP (2013). Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment . Journal of Addiction Medicine. 7 (2), 133-138.
Kinlock TW, Gordon MS, Schwartz RP, O’Grady KE (2013). Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment. Journal of Offender Rehabilitation. 52(8):509-528.
Landovitz RJ, Tseng CH, Weissman M, Haymer M, Mendenhall B, Rogers K, Veniegas R, Gorbach PM, Reback CJ, Shoptaw S (2013). Epidemiology, sexual risk behavior, and HIV prevention practices of men who have sex with men using GRINDR in Los Angeles, California. Journal of Urban Health. 90(4):729-39.
Ling Murtaugh K, Krishnamurti T, Davis AL, Reback CJ, Shoptaw S (2013). Spend today, clean tomorrow: predicting methamphetamine abstinence in a randomized controlled trial. Health Psychology.  32(9):958-66.
Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP (2013). SBIRT for adolescent drug and alcohol use: current status and future directions. Journal of Substance Abuse Treatment. 44 (5), 463-472.
Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH (2013). A randomized trial of intensive outpatient (IOP) vs. standard outpatient (OP) buprenorphine treatment for African Americans. Drug and Alcohol Dependence. 128 (3), 222-229.
Peters EN, Petry NM, Lapaglia DM, Reynolds B, Carroll KM (2013). Delay discounting in adults receiving treatment for marijuana dependence. Experimental and Clinical Psychopharmacology. 21 (1), 46-54.
Reback CJ, Fletcher JB, Shoptaw S, Grella CE (2013). Methamphetamine and other substance use trends among street-recruited men who have sex with men, from 2008 to 2011. Drug and Alcohol Dependence. 133 (1), 262-265.
Reback CJ, Larkins S (2013). HIV risk behaviors among a sample of heterosexually identified men who occasionally have sex with another male and/or a transwoman. Journal of Sex Research. 50. (2), 151-163.
Rosenthal RN, Ling W, Casadonte P, Vocci F, Bailey GL, Kampman K, Patkar A, Chavoustie S, Blasey C, Sigmon S, Beebe KL (2013). Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction. 108(12):2141-9. doi: 10.1111/add.12315. Epub 2013 Sep 18. PMID: 23919595.
Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. American Journal of Public Health.  103(5):917-22.
Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen YK, Mitchell SG, Jaffe JH (2013). Schwartz et al. respond. American Journal of Public Health. 2013 103(8):e2-3..Epub 2013 Jun 13.
Schwartz RP, Stitzer ML, Feaster DJ, Korthuis PT, Alvanzo AA, Winhusen TM, et al (2013). HIV rapid testing in drug treatment: comparison across treatment modalities. Journal of Substance Abuse Treatment. 44. (4), 369-374.
Serpelloni G, Gomma M, Genetti B, Zermiani M, Rimondo C, Mollica R, Gryczynski J, O’Grady KE, Schwartz RP (2013). Italy’s electronic health record system for opioid agonist treatment. Journal of Substance Abuse Treatment. 45(2):190-5.
2012
Bowers JR, Branson CM, Fletcher JB, Reback CJ (2012). Predictors of HIV sexual risk behavior among men who have sex with men, men who have sex with men and women, and transgender women. International Journal of Sexual Health. 24 (4), 290-302.
Caldwell D, Gryczynski J (2012). Computerized assessment facilitates disclosure of sensitive HIV risk behaviors among African Americans entering substance abuse treatment. American Journal of Drug and Alcohol Abuse. 38 (4), 365-369.
Carroll KM, Nich C, Lapaglia DM, Peters EN, Easton CJ, Petry NM (2012). Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less. Addiction. 107 (9), 1650-1659.
Coviello DM, Cornish JW, Lynch KG, Boney TY, Clark CA, Lee JD, Friedmann PDNunes EV, Kinlock TW, Gordon MS, Schwartz RP, Nuwayser ES, O’Brien CP (2012). A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers. Substance Abuse. 33 (1), 48-59. [PMCID: PMC3365863].
Friedmann PD, Hoskinson R, Gordon MS, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S, O’Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK (2012). Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Substance Abuse. 33 (1), 9-18. [PMCID: PMC3295578].
Friedmann PD, Schwartz RP (2012). Just call it "treatment". Addiction Science and Clinical Practice 7. (1), 10.
Gonzales A, Westerberg VS, Peterson TR, Moseley A, Gryczynski J, Mitchell SG, Buff G, Schwartz RP (2012). Implementing a statewide Screening, Brief Intervention, and Referral to Treatment (SBIRT) service in rural health settings: New Mexico SBIRT. Substance Abuse. 33 (2), 114-123. [PMCID: PMC3325793].
Gordon MS, Kinlock TW, Couvillion K, Schwartz RP, O’Grady KE (2012). A randomized clinical trial of methadone maintenance for prisoners: Prediction of treatment entry and completion in prison. Journal of Offender Rehabilitation. 51 (4), 222-238.
Gryczynski J, Kinlock TW, Kelly SM, O’Grady KE, Gordon MS, Schwartz RP (2012). Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime. Substance Abuse. 33 (1), 30-39.
Gryczynski J, Ward BW (2012). Religiosity, heavy alcohol use, and vicarious learning networks among adolescents in the United States. Health Education and Behavior. 39 (3), 341-351.
Kelly SM, Brown BS, Katz EC, O’Grady KE, Mitchell SG, King S, Schwartz RP (2012). A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients. The American Journal of Drug and Alcohol Abuse. 38 (3), 233-238.
Kelly SM, Schwartz RP, O’Grady KE, Gandhi D, Jaffe JH (2012). Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial. Journal of Addiction Medicine. 6 (2), 145-152. [PMCID: PMC3322294].
Landovitz RJ, Fletcher JB, Inzhakova G, Lake JE, Shoptaw S, Reback CJ (2012). A novel combination HIV prevention strategy: Post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men. AIDS Patient Care and STDs. 26 (6), 320-328.
Mitchell SG, Gryczynski J, Peterson T, Gonzales A, Moseley A, Schwartz RP (2012). Screening, Brief Intervention, and Referral to Treatment (SBIRT) for substance use in a school-based program: Services and outcomes. American Journal on Addictions. 21 S5-S13.
Mitchell SG, Kelly SM, Brown BS, O’Grady KE, Schwartz RP (2012). HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults. American Journal of Drug and Alcohol Abuse. 38 (4), 328-333.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, Jaffe JH, O’Grady KE, Olson YK, Schwartz RP (2012). African-American patients seeking treatment in the public sector: Characteristics of buprenorphine v. methadone patients. Drug and Alcohol Dependence. 122, 55-60. [PMCID: PMC3251709].
Peters EN, Budney AJ, Carroll KM (2012). Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction. 107 (8), 1404-1417.
Peters EN, Leeman RF, Fucito LM, Toll BA, Corbin WR, O’Malley SS (2012). Co-occurring marijuana use is associated with medication nonadherence and nonplanning impulsivity in young adult heavy drinkers. Addictive Behaviors. 37 (4), 420-426.
Peters EN, Torres E, Toll BA, Cummings KM, Gritz ER, Hyland A, Herbst RS, Marshall JR, Warren GW (2012). Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. Journal of Clinical Oncology. 30 (23), 2869-2875.
Reback CJ, Grant DL, Fletcher JB, Branson CM, Shoptaw S, Bowers JR, Charania M, Mansergh G (2012). Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS and Behavior. 16 (7), 1993-2002.
Reback CJ, Peck JA, Fletcher JB, Nuno M, Dierst-Davies R (2012). Lifetime substance use and HIV sexual risk behaviors predict treatment response to contingency management among homeless, substance-dependent MSM. Journal of Psychoactive Drugs. 44 (2), 166-172.
Reback CJ, Shoptaw S, Downing MJ (2012). Prevention case management improves socioeconomic standing and reduces symptoms of psychological and emotional distress among transgender women. AIDS Care. 24 (9), 1136-1144.
Schwartz RP, Kelly SM, O’Grady KE, Gandhi D, Jaffe JH (2012). Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction. 107 (5), 943-952. [PMCID: PMC3319854].
Wiechelt SA, Gryczynski J, Johnson JL, Caldwell D (2012). Historical trauma among urban American Indians: Impact on substance abuse and family cohesion. Journal of Loss and Trauma. 17 (4), 319-336.
Wilson ME, Kinlock TW, Gordon MS, O’Grady KE, Schwartz RP (2012). Post-prison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners. The American Journal on Addictions. 21 (5), 476-487.
Wilson ME, Kinlock TW, Gordon MS, O’Grady KE, Schwartz RP (2012). Post-prison HIV-risk behaviors in a randomized clinical trial of methadone maintenance treatment. American Journal on Addictions. 21, 476-487. PMCID: PMC3422766. doi: 10.1111/j.1521-0391.2012.00250.x. PMID: 22882399. PMCID: PMC3422766.
Wilson ME, Taxman FS, O’Grady KE (2012). The relationship of social networks to HIV risk behaviors from a sample of probationers in a randomized trial. The Prison Journal (PMC Journal in Process). 92 (3).
2011
Bowers JR, Branson CM, Fletcher JB, Reback CJ (2011). Differences in substance use and sexual partnering between men who have sex with men, men who have sex with men and women and transgender women. Culture, Health, and Sexuality. 13 (6), 629-642.
Dierst-Davies R, Reback CJ, Peck JA, Nuno M, Kamien JB, Amass L (2011). Delay discounting among homeless, out-of-treatment, substance-dependent men who have sex with men. The American Journal of Drug and Alcohol Abuse. 37 (2), 93-97.
Gordon MS, Kinlock TW, Miller PM (2011). Medication-assisted treatment research with criminal justice populations: challenges of implementation. Behavioral Sciences and the Law. 29 (6), 829-845. [PMCID: PMC3243915].
Gryczynski J, Johnson J (2011). Special issue on Native Americans and substance use. Substance Use and Misuse. 46 (11), 1359-1362.
Gryczynski J, Johnson JL (2011). Challenges in public health research with American Indians and other small ethnocultural minority populations. [Review]. Substance Use and Misuse. 46 (11), 1363-1371.
Gryczynski J, Mitchell SG, Peterson TR, Gonzales A, Moseley A, Schwartz RP (2011). The relationship between services delivered and substance use outcomes in New Mexico's Screening, Brief Intervention, Referral and Treatment (SBIRT) Initiative. Drug and Alcohol Dependence. 118 (2-3), 152-157. [PMCID: PMC21482039].
Gryczynski J, Schwartz RP, Salkever DS, Mitchell SG, Jaffe JH (2011). Patterns in admission delays to outpatient methadone treatment in the United States. Journal of Substance Abuse Treatment. 41 (4), 431-439. [PMCID: PMC3205308].
Gryczynski J, Ward BW (2011). Social norms and the relationship between cigarette use and religiosity among adolescents in the United States. Health Education and Behavior. 38 (1), 39-48.
Hughes JR, Peters EN, Naud S (2011). Effectiveness of over-the-counter nicotine replacement therapy: A qualitative review of non-randomized trials. Nicotine and Tobacco Research. 13 512-522.
Johnson JL, Gryczynski J, Moe J (2011). Treatment issues and interventions with young children and their substance-abusing parents. In SLA Straussner & CH Fewell (Eds.). Children of Substance Abusing Parents: Dynamics and Treatment. (pp. 101-125). New York: Springer.
Katz EC, Brown BS, Schwartz RP, O’Grady KE, King SD, Gandhi D (2011). Transitioning opioid-dependent patients from detoxification to long-term treatment: Efficacy of intensive role induction. Drug and Alcohol Dependence. 117 (1), 24-30. [PMCID: PMC3090541].
Kelly SM, O’Grady KE, Mitchell SG, Brown BS, Schwartz RP (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence. 117. (2-3), 170-175. [PMCID: PMC3148301].
Kinlock TW (2011). Commentary on Huang et al.: New questions and directions for future research emanating from an evaluation of the effectiveness of a harm reduction program. Addiction. 106 1446-1447.
Kinlock TW, Gordon MS, Schwartz RP (2011). Incarcerated populations. In P. Ruiz & E. Strain (Eds.). Lowinson & Ruiz’s Substance Abuse: A Comprehensive Textbook. (Fifth ed., pp. 881-891). Philadelphia, PA: Lippincott Williams & Wilkins.
Mitchell SG, Morioka R, Reisinger HS, Peterson JA, Kelly SM, Agar MH, Schwartz RP, et al (2011). Redefining retention: recovery from the patient's perspective. Journal of Psychoactive Drugs. 43 (2), 99-107. [PMCID: PMC3160714].
Peters EN, Nich C, Carroll KM (2011). Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders. Drug and Alcohol Dependence. 118 (2-3), 408-416.
Reback CJ, Shoptaw S (2011). Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men. Addictive Behaviors. [Epub ahead of print].
Rich JD, McKenzie M, Dickman S, Bratberg J, Lee JD, Schwartz RP (2011). An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison: A Case Report. Addictive Disorders and their Treatment. 10 (4), 199-200. PMCID: PMC3222590.
Schwartz RP, Kelly SM, O’Grady KE, Gandhi D, Jaffe JH (2011). Interim methadone treatment compared to standard methadone treatment: 4-Month findings. Journal of Substance Abuse Treatment. 41 (1), 21-29. [PMCID: PMC3110526].
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Brown BS (2011). Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts. Drug and Alcohol Dependence. 115 (1-2), 23-29. [PMCID: PMC3059350].
Schwartz RP, Mitchell SG, Gordon MS, and Kinlock TW (2011). Pharmocotherapy. In C. Leukefeld, J. Gregrich & T. P. Gullotta (Eds.), . Handbook on Evidence-Based Substance Abuse Treatment Practice in Criminal Justice Settings, Issues in Childrens’ and Families’ Lives 11.  (pp. 259-277). New York: Springer Publishing.
Wiechelt SA, Gryczynski J (2011). Cultural and historical trauma among Native Americans. In S. Ringel & J. R. Brandell (Eds.), . Trauma: Contemporary Directions in Theory, Practice, and Research.  (pp. 191-222). Thousand Oaks, CA: Sage.
2010
Della LJ, DeJoy DM, Mitchell SG, Goetzel RZ, Chung-Roemer E, Wilson MG (2010). Management support and workplace health promotion: Field test of the Leading by Example (LBE) assessment tool. American Journal of Health Promotion. 25 (2), 138-146.
Gryczynski J, Feldman R, Carter-Pokras O, Kanamori M, Chen L, Roth S (2010). Contexts of tobacco use and perspectives on smoking cessation among a sample of urban American Indians. Journal of Health Care for the Poor and Underserved. 21 (2), 544-558.
Hughes JR, Solomon LJ, Livingston AE, Callas PW, Peters EN (2010). A randomized controlled trial of NRT-assisted gradual vs. abrupt smoking cessation. Drug and Alcohol Dependence. 111 105-113.
Johnson BA, Elkashef AM, Seneviratne C, Ait-Dauod N, Kahn RC, Li SH, Bloch DA, Holmes TH, Wang XQ, Vocci FJ, Jr Li MD, and the Methamphetamine Study Group (2010). Association between genotype of the serotonin transporter linked polymorphic region of the serotonin transporter gene and age of onset of methamphetamine use: a preliminary analysis. Frontiers in Psychiatry. 1, 145.
Johnson JL, Baldwin J, Gryczynski J, Wiechelt SA, Haring RC (2010). The Native American experience: From displacement and cultural trauma to resilience. In H. McCubbin, K. Ontai, L. Kehl, et al. (Eds.), . Multiethnicity and Multiethnic Families: Development, Identity, and Resilience.  (pp. 277-301). Honolulu, HI: Le’A Publications.
Kelly SM, O’Grady KE, Brown BS, Mitchell SG, Schwartz RP (2010). The role of patient satisfaction in methadone treatment. American Journal of Drug and Alcohol Abuse, 36. (3), 150-154. [PMCID: PMC2938880].
Kelly SM, O’Grady KE, Schwartz RP, Peterson JA, Wilson ME, Brown BS (2010). The relationship of social support to treatment entry and engagement: The community assessment inventory. Substance Abuse. 31 (1), 43-52. [PMCID: PMC2856126].
Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT (2010). Developing and implementing a new prison-based buprenorphine treatment program. Journal of Offender Rehabilitation. 49 (2), 91-109. [PMCID: PMC2868193].
Mitchell SG, Lounsbury D (2010). Community Psychology. In C. S. Clauss-Ehlers (Ed.). Encyclopedia of Cross-Cultural School Psychology.  (pp. 249-256). New York, NY: Springer.
Peters EN, Hughes JR (2010). Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence . Drug and Alcohol Dependence. 106 (2-3), 111-118.
Peterson JA, Schwartz RP, Mitchell SG, Reisinger HS, Kelly SM, O’Grady KE, Brown BS, Agar MH (2010). Why don’t out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy. 21 36-42. [PMCID: PMC2790538].
Reback CJ, Larkins S (2010). Maintaining a heterosexual identity: Sexual meanings among a sample of heterosexually identified men who have sex with men. Archives of Sexual Behavior. 39 (3), 766-773.
Reback CJ, Ling D, Shoptaw S, Rohde J (2010). Developing a Text Messaging Risk Reduction Intervention for Methamphetamine-Using MSM: Research Note. The Open AIDS Journal. 4 116-122.
Reback CJ, Peck JA, Dierst-Davies R, Nuno M, Kamien JB, Amass A (2010). Contingency management among homeless, out-of-treatment men who have sex with men. Journal of Substance Abuse Treatment. 39 (3), 255-263.
Wilson ME, Schwartz RP, O’Grady KE, Jaffe JH (2010). Impact of interim methadone maintenance on HIV risk behaviors. Journal of Urban Health. 87 (4), 586-591. [PMCID: PMC2900571].
2009
Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo DD, Ackis C, Roache JD, Salloum IM, Somoza E, Urschel HC 3rd, Elkashef AM (2009). Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence. 104(1-2), 133-139.
Carswell SB, Hanlon TE, O’Grady KE, Watts A, Pothhong P (2009). A preventive intervention program for urban African American youth attending an alternative education program: Background, implementation, and feasibility.  Education and Treatment of Children.
Chandler RK, Dennis ML, El-Bassel N, Schwartz RP, Field G (2009). Ensuring safety, implementation and scientific integrity of clinical trials: less from the Criminal Justice-Drug Abuse Treatment Studies Data and Safety Monitoring Board. Journal of Experimental Criminology. 5(3), 324-244.
Frye V, Fortin P, MacKenzie S, Purcell D, Edwards LV, Mitchell SG, Valverde E, Garfein RS, Metsch L, Latka MH (2009). Managing identity impacts associated with disclosure of HIV status: A qualitative investigation. AIDS Care. 21(8), 1071-1078.
Gryczynski J, Schwartz RP, O’Grady K, Jaffe JH (2009). Dropout from interim methadone and subsequent comprehensive methadone maintenance. American Journal of Drug and Alcohol Abuse. 35, 394-398.
Gryczynski J, Schwartz RP, O’Grady K, Jaffe JH (2009). Treatment entry among individuals on a waiting list for methadone maintenance.  American Journal of Drug and Alcohol Abuse. 35(5), 290-294. Abstract.
Hanlon TE, Simon BD, O’Grady KE, Carswell SB, Callaman JM (2009). The effectiveness of an after-school program targeting urban African American youth. Education and Urban Society.
In J M Roll RA Rawson W Ling and SShoptaw (Eds) Vocci FJ, Elkashef E, Appel NM (2009). Pharmacological treatment of methamphetamine addiction. Methamphetamine addiction: From basic science to treatment. (pp 202-229) New York: Guilford Press.
Johanson CE, Balster RL, Henningfield JE, Schuster CR, Anthony JC, Barthwell AG, Coleman JJ, DArt R, Gorodetzky CW, O’Keeffe C, Sellers EM, Vocci F, Walsh SL (2009). Risk-management and post-marketing surveillance for the abuse of medications acting on the central nervous system: expert panel report. Drug and Alcohol Dependence. 105(Suppl 1), 565-571.
Katz EC, Schwartz RP, King SD, Highfield DA, O’Grady KE, Billings T, Gandhi D, Weintraub E, Glovinsky D, Barksdale W, Brown BS (2009). Brief v. extended buprenorphine detoxification in a community treatment program: Engagement and short-term outcomes.  American Journal of Drug and Alcohol Dependence.
Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals. American Journal of Drug and Alcohol Abuse. 35, 38-42.
Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O’Grady KE (2009). Methadone maintenance for prisoners: Results at twelve-months post-release. Journal of Substance Abuse Treatment. 37, 277-285.
Kinlock TW, Sears EA, O’Grady KE, Callaman JM, Brown BS (2009). Treatment retention and changes in motivation among drug court probationers.  Journal of Offender Rehabilitation.
Lounsbury DW Mitchell SG (2009). Introduction to special issue on social ecological approaches to community health research and action. American Journal of Community Psychology. 44(3/4), 213-220. doi: 10.1007/s10464-009-9266-4. PMID: 19777338.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, O’Grady KE Schwartz RP (2009). Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland. The American Journal on Addictions.
Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, Schwartz RP (2009). Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users.  Journal of Psychoactive Drugs.
Schnavia H, Toldson I, Godette D, Richardson J (2009). Mental Health, Substance Abuse, and HIV Disparities in Correctional Settings: Practice and Policy Implications for African Americans. Journal of Health Care for the Poor and Underserved.
Schwartz RP, Jaffe JH, O’Grady K, Das B, Highfield DA, Wilson ME (2009). Scaling-up interim methadone maintenance: Treatment for 1,000 heroin addicts. Journal of Substance Abuse Treatment. 37(4), 362-367. PMCID: PMC2796977.
Schwartz RP, Jaffe JH, O’Grady KE, Kinlock TW, Gordon MS, Kelly SM, Wilson ME, Ahmed A (2009). Interim Methadone Treatment: Impact on Arrests.  Drug and Alcohol Dependence. 103, 148-154. doi: 10.1016/j.drugalcdep.2009.03.007. Epub 2009 May 14. PMID: 19443133.
Vocci FJ, Montoya ID (2009). Psychological treatments for stimulant misuse: comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Current Opinion in Psychiatry. 23(3), 263-268.
Ward B, Gryczynski J (2009). Social learning theory and the effects of living arrangement on heavy alcohol use: Results from a national study of college students. Journal of Studies on Alcohol. 70, 364-372.
Wiechelt SA, Gryczynski J, Johnson JL (2009). Designing HIV preventative interventions for urban American Indians: Evolution of ‘The Don’t Forget Us’ program.  Health & Social Work. 34(4), 301-304.
2008
Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J, Acri J (2008). Pharmacotherapy of methamphetamine addiction: An update. Substance Abuse. 29(3), 31-50. PMCID: PMC2597382.
Elkashef AM, Rawson RA, Anderson AL, Li SH, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VL, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D (2008). Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology. 33(5), 1162-1170.
Friedmann PD, Katz EC, Rhodes AG, Taxman FS, O’Connell DJ, Frisman LK, Burdon WM, Fletcher BW, Litt MD, Martin SS (2008). Collaborative Behavioral Management for Drug-Involved Parolees: Rationale and Design of the Step’N Out Study.  Journal of Offender Rehabilitation. 47, 290-318.
Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6-months post-release. Addiction. 103 (8), 1333-1342.
Johnson BA, Ait-Daoud N, Elkashef AM, Smith EV, Kahn R, Vocci F, Li SH, Bloch DA (2008). Methamphetamine Study Group: a preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. The International Journal of Neuropsychopharmacology. 11(1), 1-17.
Kinlock TW, Gordon MS, Schwartz RP, O’Grady KE (2008). A study of methadone maintenance for male prisoners: Three-month post-release outcomes. Criminal Justice and Behavior. 35 (1), 34-47.
Marsella A, Johnson J, Watson P, Gryczynski J, Eds (2008). Ethnocultural Perspectives on Disaster and Trauma: Foundations, Issues, and Applications. New York, Springer.
Mitchell SG, Goetzel RZ, Ozminkowski RJ (2008). The value of worksite health promotion. ACSM's. Heath and Fitness Journal. 12(2), 23-27.
Peterson JP, Schacht-Reisinger H, Schwartz RP, Mitchell SG, Kelly SM, Brown BS, Agar MH (2008). Targeted sampling in drug abuse research: A review and case study.  Field Methods. 20(2), 155-170.
Reback CJ, Shoptaw S, Grella CE (2008). Methamphetamine use trends among street-recruited Gay and Bisexual males, from 1999 to 2007. Journal of Urban Health. 85(6): 874-879.
Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O’Grady KE, Marrari EA, Brown BS, Agar MH (2008). Premature discharge from methadone treatment: Patient perspectives. Journal of Psychoactive Drugs.
Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS (2008). Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addictions. 17(5), 396-401.
Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Agar MH, Brown BS (2008). In-treatment v. out-of-treatment opioid dependent adults: Drug use and criminal history. American Journal of Drug and Alcohol Abuse. 34(1), 17-28.
Shoptaw S, Reback C, Larkins S, Wang J, Rotheram-Fuller E, Dang J, Yang X (2008). Outcomes using two tailored behavioral treatments for substance abuse in urban Gay and Bisexual Men. Journal of Substance Abuse Treatment. 35(3): 285-293.
Shoptaw S, Rotheram-Fuller E, Landovitz R, Wang J, Moe A, Reback CJ, Kanouse D (2008). Non-occupational post exposure prophylaxis as a biobehavioral HIV prevention intervention. AIDS Care. 20(3): 376-381.
Somoza E, Somoza P, Lewis D, Li SH, Winhusen T, Chiang N, Vocci F, Horn P, Elkashef E (2008). A new outcome measure for use in pharmacotherapy trials for cocaine dependence. Drug and Alcohol Dependence. 93, 132-140.
Vocci F (2008). Cognitive remediation in the treatment of substance abuse disorders: A research agenda. Experimental and Clinical Psychopharmacology. 6(6), 484-497.